Currently holds a position at Corcept Therapeutics Inc
Position | Company | Period |
---|---|---|
Senior Vice President - Commercial | Corcept Therapeutics Inc | April 1, 2016 - |
Vice President of Sales and Marketing | Corcept Therapeutics Inc | None - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-20 | 2024-03-18 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
17,219
-18.6%
25.00430,475 USD |
17,219 -18.6% | 25.00 | 430,475 USD | |
2024-02-20 | 2024-02-16 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
27,068
-26.7%
25.97702,905 USD |
27,068 -26.7% | 25.97 | 702,905 USD | |
2024-02-20 | 2024-02-15 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
4,760
-6.0%
25.00119,000 USD |
4,760 -6.0% | 25.00 | 119,000 USD | |
2023-11-03 | 2023-11-01 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
5,112
-6.5%
28.08143,545 USD |
5,112 -6.5% | 28.08 | 143,545 USD | |
2023-10-12 | 2023-10-10 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
18,471
-20.1%
27.29504,038 USD |
18,471 -20.1% | 27.29 | 504,038 USD | |
2023-10-10 | 2023-10-06 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
3,498
-4.5%
27.2495,286 USD |
3,498 -4.5% | 27.24 | 95,286 USD | |
2023-10-04 | 2023-10-02 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
3,031
-4.0%
27.2482,577 USD |
3,031 -4.0% | 27.24 | 82,577 USD | |
2023-09-20 | 2023-09-19 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
25,000
-25.4%
32.48812,000 USD |
25,000 -25.4% | 32.48 | 812,000 USD | |
2022-12-05 | 2022-12-01 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
625
-1.1%
25.2815,800 USD |
625 -1.1% | 25.28 | 15,800 USD | |
2022-11-15 | 2022-11-10 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
25,000
-30.7%
25.57639,250 USD |
25,000 -30.7% | 25.57 | 639,250 USD | |
2022-10-04 | 2022-10-03 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
25,000
-30.7%
25.64641,000 USD |
25,000 -30.7% | 25.64 | 641,000 USD | |
2022-09-06 | 2022-09-01 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
25,000
-31.4%
25.84646,000 USD |
25,000 -31.4% | 25.84 | 646,000 USD | |
2022-08-11 | 2022-08-09 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
200
-0.5%
28.705,740 USD |
200 -0.5% | 28.70 | 5,740 USD | |
2022-07-19 | 2022-07-18 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
25,000
-38.4%
27.37684,250 USD |
25,000 -38.4% | 27.37 | 684,250 USD | |
2021-10-05 | 2021-10-05 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
637
-1.6%
20.0012,740 USD |
637 -1.6% | 20.00 | 12,740 USD | |
2021-10-05 | 2021-10-01 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
24,363
-37.8%
20.00487,375 USD |
24,363 -37.8% | 20.00 | 487,375 USD | |
2021-09-03 | 2021-09-01 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
25,000
-38.4%
21.40534,930 USD |
25,000 -38.4% | 21.40 | 534,930 USD | |
2021-02-16 | 2021-02-16 |
Corcept Therapeutics Inc
(CORT)
|
S Sale |
8,989
-23.0%
28.25253,903 USD |
8,989 -23.0% | 28.25 | 253,903 USD | |
2021-02-16 | 2021-02-11 |
Corcept Therapeutics Inc
(CORT)
|
S Sale |
3,400
-10.2%
29.78101,249 USD |
3,400 -10.2% | 29.78 | 101,249 USD |